Neurimmune Enhances Partnership with AstraZeneca for AL Amyloidosis Treatment Neurimmune expands its collaboration with AstraZeneca to advance NI009 targeting AL amyloidosis. This partnership aims to enhance treatment options for patients.

Neurimmune Enhances Partnership with AstraZeneca for AL Amyloidosis Treatment #AstraZeneca #Switzerland #Zurich #AL_Amyloidosis #Neurimmune

Protego Biopharma Secures $130 Million to Propel AL Amyloidosis Research Forward Protego Biopharma has raised $130 million in an oversubscribed Series B funding round, aiming to advance its groundbreaking therapy for AL amyloidosis into pivotal clinical trials.

Protego Biopharma Secures $130 Million to Propel AL Amyloidosis Research Forward #USA #San_Diego #AL_Amyloidosis #Protego_Biopharma #PROT-001

Stand Up To Cancer Funds New Research to Tackle AL Amyloidosis Treatments Stand Up To Cancer is funding a team exploring innovative treatments for AL amyloidosis. This initiative aims to improve the lives of patients affected by this rare disease.

Stand Up To Cancer Funds New Research to Tackle AL Amyloidosis Treatments #USA #Los_Angeles #Cancer_Research #Stand_Up_To_Cancer #AL_Amyloidosis